This pattern will likely be reproduced with future high-demand therapies, forcing regulators, manufacturers, and clinicians to balance access, safety, and incentives for innovation as more care moves outside traditional clinical settings and insurer-mediated systems.
Noom counter-positioned against WeightWatchers' (NYSE: WW) brand of in-person weight loss support groups (mainly for older women) as a mobile-native, science-backed app with fully-virtual text-based coaching, targeting ex-WeightWatchers users and capturing the upside of their decline (WeightWatchers revenue steadily declined from $1.83B in 2012 to $890M in 2023)
Well take the time to discuss your medical history, current medications, and overall rehabilitation goals to create a plan that supports your long-term health and well-being
The strategies for preventing cardiovascular and renal events in patients with diabetes are becoming increasingly diverse
PMID: 20923958
and in this trial, the relative risk of MACE was reduced by 26% [21]
